Creative Medical Technology Holdings, Inc. (CELZ) stock
CELZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.48−0.04 (-8.36%)
Close on Nov 17, 2026Market cap $3.14MP/E –Yield –
Creative Medical Technology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Creative Medical Technology's revenue for the twelve months ending Jun 30, 2026 was $3.00K, down 50.0% year over year. For fiscal 2025 it was $6.00K, down 45.5% from the year before. The highest annual figure on record is $165.50K in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.00K | -45.5% |
| FY2024 | Dec 31, 2024 | $11.00K | +22.2% |
| FY2023 | Dec 31, 2023 | $9.00K | -89.8% |
| FY2022 | Dec 31, 2022 | $88.60K | +1.0% |
| FY2021 | Dec 31, 2021 | $87.75K | -46.7% |
| FY2020 | Dec 31, 2020 | $164.50K | -0.6% |
| FY2019 | Dec 31, 2019 | $165.50K | +33.0% |
| FY2018 | Dec 31, 2018 | $124.40K | +2491.7% |
| FY2017 | Dec 31, 2017 | $4.80K | – |
| FY2016 | Dec 31, 2016 | $0 | – |
| FY2015 | Dec 31, 2015 | $0 | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
| FY2012 | Dec 31, 2012 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0 | – |
| Q1 FY2026 | Mar 31, 2026 | $0 | -100.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.00K | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | $0 | – |
| Q2 FY2025 | Jun 30, 2025 | $0 | -100.0% |
| Q1 FY2025 | Mar 31, 2025 | $3.00K | – |
| Q4 FY2024 | Dec 31, 2024 | $3.00K | 0.0% |
| Q3 FY2024 | Sep 30, 2024 | $0 | -100.0% |
| Q2 FY2024 | Jun 30, 2024 | $8.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $0 | – |
| Q4 FY2023 | Dec 31, 2023 | $3.00K | -83.9% |
| Q3 FY2023 | Sep 30, 2023 | $6.00K | -89.1% |
| Q2 FY2023 | Jun 30, 2023 | $0 | – |
| Q1 FY2023 | Mar 31, 2023 | $0 | -100.0% |
| Q4 FY2022 | Dec 31, 2022 | $18.60K | -72.5% |
| Q3 FY2022 | Sep 30, 2022 | $55.00K | +450.0% |
| Q2 FY2022 | Jun 30, 2022 | $0 | -100.0% |
| Q1 FY2022 | Mar 31, 2022 | $15.00K | – |
| Q4 FY2021 | Dec 31, 2021 | $67.75K | +287.2% |
| Q3 FY2021 | Sep 30, 2021 | $10.00K | -87.0% |
| Q2 FY2021 | Jun 30, 2021 | $10.00K | -64.2% |
| Q1 FY2021 | Mar 31, 2021 | $0 | -100.0% |
| Q4 FY2020 | Dec 31, 2020 | $17.50K | -69.6% |
| Q3 FY2020 | Sep 30, 2020 | $77.00K | +25.0% |
| Q2 FY2020 | Jun 30, 2020 | $27.90K | -45.1% |
| Q1 FY2020 | Mar 31, 2020 | $42.10K | -26.9% |
| Q3 FY2019 | Sep 30, 2019 | $57.50K | +9.7% |
| Q2 FY2019 | Jun 30, 2019 | $61.60K | +1183.3% |
| Q1 FY2019 | Mar 31, 2019 | $50.80K | +429.2% |
| Q4 FY2018 | Dec 31, 2018 | $57.60K | +1100.0% |
| Q3 FY2018 | Sep 30, 2018 | $52.40K | – |
| Q2 FY2018 | Jun 30, 2018 | $4.80K | – |
| Q1 FY2018 | Mar 31, 2018 | $9.60K | – |
| Q4 FY2017 | Dec 31, 2017 | $4.80K | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |
See a number that looks wrong?